This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bouza, E.
Right arrow Articles by Diaz, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bouza, E.
Right arrow Articles by Diaz, M. S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 1999, p. 981-982, Vol. 43, No. 4
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Pseudomonas aeruginosa: a Survey of Resistance in 136 Hospitals in Spain

E. Bouza,* F. Garcia-Garrote, E. Cercenado, M. Marin, and M. S. Diaz for The Spanish Pseudomonas aeruginosa Study Group

Servicio de Microbiología y Enfermedades Infecciosas-VIH, Hospital General Universitario "Gregorio Marañón," 28007 Madrid, Spain

Received 10 November 1998/Returned for modification 17 December 1998/Accepted 5 February 1999

We carried out a nationwide study with all of the isolates of Pseudomonas aeruginosa collected in a week in 136 hospitals in Spain. The data on 1,014 isolates included resistance to the following antimicrobials: piperacillin-tazobactam, 7%; meropenem, 8%; amikacin, 9%; tobramycin, 10%; piperacillin, 10%; ticarcillin, 13%; imipenem, 14%; ceftazidime, 15%; cefepime, 17%; ciprofloxacin, 23%; aztreonam, 23%; ofloxacin, 30%; gentamicin, 31%. The most frequent serotypes were O:1 (25.1%), O:4 (21.6%), and O:11 (11.3%).

* Corresponding author. Mailing address: Servicio de Microbiología y Enfermedades Infecciosas-VIH, Hospital General Universitario "Gregorio Marañón," Dr. Esquerdo 46, 28007 Madrid, Spain. Phone: 91-5868453. Fax: 91-3721721. E-mail: ebouza{at}microb.net.

Antimicrobial Agents and Chemotherapy, April 1999, p. 981-982, Vol. 43, No. 4
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Gutierrez, O., Juan, C., Cercenado, E., Navarro, F., Bouza, E., Coll, P., Perez, J. L., Oliver, A. (2007). Molecular Epidemiology and Mechanisms of Carbapenem Resistance in Pseudomonas aeruginosa Isolates from Spanish Hospitals. Antimicrob. Agents Chemother. 51: 4329-4335 [Abstract] [Full Text]  
  • Alou, L., Aguilar, L., Sevillano, D., Gimenez, M.-J., Echeverria, O., Gomez-Lus, M.-L., Prieto, J. (2005). Is there a pharmacodynamic need for the use of continuous versus intermittent infusion with ceftazidime against Pseudomonas aeruginosa? An in vitro pharmacodynamic model. J Antimicrob Chemother 55: 209-213 [Abstract] [Full Text]  
  • Van Eldere, J. (2003). Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J Antimicrob Chemother 51: 347-352 [Abstract] [Full Text]  
  • Luzzaro, F., Mantengoli, E., Perilli, M., Lombardi, G., Orlandi, V., Orsatti, A., Amicosante, G., Rossolini, G. M., Toniolo, A. (2001). Dynamics of a Nosocomial Outbreak of Multidrug-Resistant Pseudomonas aeruginosa Producing the PER-1 Extended-Spectrum {beta}-Lactamase. J. Clin. Microbiol. 39: 1865-1870 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»